This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Citing articles on Web of Science (4)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: Human immunodeficiency virus 1 (HIV-1) antigen-specific proliferative CD4⁺ T cell responses are typically absent in patients with chronic HIV-1 infection.¹ However, these responses are present in so-called long-term nonprogressors who experience control of viremia even without treatment^1-3 and in patients treated with highly active antiretroviral therapy (HAART) during acute seroconversion who are subsequently able to contain viremia after treatment interruptions.⁴ These findings suggest that the presence of CD4⁺ T cell proliferative responses to HIV-1 may be associated with protection against viral replication.

Methods

We studied 2 patients who were started on HAART during chronic infection and who were unusual in that they had strong and broad HIV-1–specific CD4⁺ T cell responses. Both patients experienced treatment interruptions, which allowed us to examine the relationship between strong proliferative responses to HIV-1 and the control of viremia. Blood was obtained from both patients at various times before and after the discontinuation . . . [Full Text of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Antiretroviral therapy in sub-Saharan Africa: myth or reality?
Kebba
J Antimicrob Chemother 2003;52:747-749.
FULL TEXT